These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 1900225)
61. Association of plasma levels of activated protein C with recanalization of the infarct-related coronary artery after thrombolytic therapy in acute myocardial infarction. Takazoe K; Ogawa H; Yasue H; Sakamoto T; Oshima S; Arai H; Moriyama Y; Shimomura H; Hirai N; Kaikita K; Soejima H; Misumi K; Hosoda K Thromb Res; 1999 Jul; 95(1):37-47. PubMed ID: 10403685 [TBL] [Abstract][Full Text] [Related]
62. Unresolved clinical pharmacologic questions in thrombolytic therapy for acute myocardial infarction. Sherry S J Am Coll Cardiol; 1988 Aug; 12(2):519-25. PubMed ID: 3134481 [TBL] [Abstract][Full Text] [Related]
63. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators. Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177 [TBL] [Abstract][Full Text] [Related]
64. Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction. GUSTO-III Investigators. Serebruany VL; Gurbel PA; Shustov AR; Dalesandro MR; Gumbs CI; Grabletz LB; Bahr RD; Ohman EM; Topol EJ Stroke; 1998 Jan; 29(1):235-8. PubMed ID: 9445356 [TBL] [Abstract][Full Text] [Related]
65. Fibrinogen breakdown, long-lasting systemic fibrinolysis, and procoagulant activation during alteplase double-bolus regimen in acute myocardial infarction. Stangl K; Laule M; Tenckhoff B; Stangl V; Gliech V; Dübel P; Grohmann A; Melzer C; Langel J; Wernecke KD; Baumann G; Ziemer S Am J Cardiol; 1998 Apr; 81(7):841-7. PubMed ID: 9555772 [TBL] [Abstract][Full Text] [Related]
66. Soluble, thrombin-related material in arterial thrombi and plasma studied during catheter-directed intra-arterial thrombolysis. Sandbaek G; Bjørnsen S; Brosstad F Blood Coagul Fibrinolysis; 1999 Mar; 10(2):87-91. PubMed ID: 10192657 [TBL] [Abstract][Full Text] [Related]
67. [Platelet activation in the early phases of acute myocardial infarction]. Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873 [TBL] [Abstract][Full Text] [Related]
68. Is there a phase of hypercoagulability when aprotinin is used in cardiac surgery? Feindt P; Seyfert U; Volkmer I; Huwer H; Kalweit G; Gams E Eur J Cardiothorac Surg; 1994; 8(6):308-13; discussion 313-4. PubMed ID: 7522017 [TBL] [Abstract][Full Text] [Related]
69. Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction. Van de Werf F; Nobuhara M; Collen D Ann Intern Med; 1986 Mar; 104(3):345-8. PubMed ID: 3080936 [TBL] [Abstract][Full Text] [Related]
70. [Thrombolytic drugs in acute myocardial infarct]. Ambrosioni E; Degli Esposti D Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796 [TBL] [Abstract][Full Text] [Related]
72. Effects of lipoprotein(a) on thrombolysis. von Hodenberg E; Pestel E; Kreuzer J; Freitag M; Bode C Chem Phys Lipids; 1994 Jan; 67-68():381-5. PubMed ID: 8187238 [TBL] [Abstract][Full Text] [Related]
73. Frequency of "optimal anticoagulation" for acute myocardial infarction after thrombolysis with front-loaded recombinant tissue-type plasminogen activator and conjunctive therapy with recombinant hirudin (HBW 023). ALKK Study Group. Zeymer U; von Essen R; Tebbe U; Niederer W; Mäurer W; Vogt A; Neuhaus KL Am J Cardiol; 1995 Nov; 76(14):997-1001. PubMed ID: 7484879 [TBL] [Abstract][Full Text] [Related]
74. Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. The TAMI Investigators. Thrombolysis and Angioplasty in Acute Myocardial Infarction. Ward SR; Sutton JM; Pieper KS; Schwaiger M; Califf RM; Topol EJ Am J Cardiol; 1997 Mar; 79(5):539-44. PubMed ID: 9068505 [TBL] [Abstract][Full Text] [Related]
75. Serum lipoprotein(a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction. Haider AW; Andreotti F; Thompson GR; Kluft C; Maseri A; Davies GJ Circulation; 1996 Nov; 94(9):2072-6. PubMed ID: 8901653 [TBL] [Abstract][Full Text] [Related]
76. Comparison of saruplase and alteplase in acute myocardial infarction. SESAM Study Group. The Study in Europe with Saruplase and Alteplase in Myocardial Infarction. Bär FW; Meyer J; Vermeer F; Michels R; Charbonnier B; Haerten K; Spiecker M; Macaya C; Hanssen M; Heras M; Boland JP; Morice MC; Dunn FG; Uebis R; Hamm C; Ayzenberg O; Strupp G; Withagen AJ; Klein W; Windeler J; Hopkins G; Barth H; von Fisenne MJ Am J Cardiol; 1997 Mar; 79(6):727-32. PubMed ID: 9070549 [TBL] [Abstract][Full Text] [Related]
77. Soluble vascular cell adhesion molecule-1 and E-selectin in patients with acute myocardial infarction treated with thrombolytic agents. Gurbel PA; Serebruany VL Am J Cardiol; 1998 Mar; 81(6):772-5. PubMed ID: 9527091 [TBL] [Abstract][Full Text] [Related]
78. Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: in-hospital course and relationship with recurrent angina at rest. Figueras J; Monasterio Y; Lidón RM; Nieto E; Soler-Soler J J Am Coll Cardiol; 2000 Dec; 36(7):2036-43. PubMed ID: 11127437 [TBL] [Abstract][Full Text] [Related]
80. [Thrombolysis with plasminogen activators: use and research of serine proteinases, promise and actuality]. Maksimenko AV Biomed Khim; 2014; 60(6):677-82. PubMed ID: 25552508 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]